New nerve agent antidotes in sight, say researchers
3 May 2016 | By Victoria White, Digital Content Producer
The deadly nerve agent sarin can be stopped if treated with an antidote. Now, a new study describes how such a drug works...
List view / Grid view
News
Hsp90 inhibitors could treat lethal resistant prostate cancers
1 May 2016 | By Victoria White, Digital Content Producer
Researchers found that Hsp90 inhibitors target and inactivate a mechanism commonly used by prostate cancer cells to evade the effects of standard treatment...
Cell transplant that responds to designer drugs treats Parkinson’s disease
28 April 2016 | By Victoria White, Digital Content Producer
Su-Chun Zhang created two related cell types. When the cells detect the designer drug, one type ramps up production of dopamine; the other chokes it off...
A new target for the treatment of bacterial infections
28 April 2016 | By Victoria White, Digital Content Producer
Researchers at Lund University have identified a new therapeutic target for the treatment of bacterial infections that regulates the immune response...
New €2.25m international project to tackle diabetes-related blindness
28 April 2016 | By Victoria White, Digital Content Producer
A new €2.25m US-Ireland R&D partnership has been set up to develop a gene therapy approach with the aim of potentially reversing diabetes-related blindness...
Nanoparticles hold promise in the fight against genital herpes
28 April 2016 | By Victoria White, Digital Content Producer
Researchers have shown that zinc-oxide nanoparticles can prevent genital herpes virus from entering cells, and help natural immunity to develop...
Nutlin-3 reverses damage from the mutation that causes fragile X
27 April 2016 | By Victoria White, Digital Content Producer
Fragile x mice models treated with Nutlin-3 regained the ability to remember what they had seen, and smelled, in their first visit to a test chamber...
A new way to grow rare blood stem cells
27 April 2016 | By Victoria White, Digital Content Producer
A new discovery illustrates how a protein called Musashi-2 regulates the function and development of important blood stem cells...
Alteration of protein synthesis could treat neurodegeneration
27 April 2016 | By Victoria White, Digital Content Producer
New Salk research suggests that rapamycin could target the neural damage associated with Leigh syndrome and other forms of neurodegeneration as well...
VTU Technology and Boehringer Ingelheim extend collaboration
27 April 2016 | By Victoria White, Digital Content Producer
After successful completion of a first development programme, Boehringer Ingelheim is now widening the scope of its collaboration with VTU Technology...
MRC Technology to review DEBRA Austria’s Epidermolysis Bullosa portfolio
26 April 2016 | By Victoria White, Digital Content Producer
The review will identify promising projects and results which could be suitable for translation into better treatments for Epidermolysis Bullosa...
Queen’s University Belfast and Domainex secure award to advance FLIP inhibitor
26 April 2016 | By Victoria White, Digital Content Producer
Queen’s University Belfast and Domainex have secured an award to advance therapeutic candidate molecules into clinical evaluation for treatment of NSCLC...
Heptares scientists solve structures of GLP-1 and glucagon receptors
25 April 2016 | By Victoria White, Digital Content Producer
Heptares scientists have solved the high-resolution X-ray crystal structures of the GLP-1 (glucagon-like peptide 1) and glucagon receptors...
T-cell discovery could lead to disease breakthroughs
25 April 2016 | By Victoria White, Digital Content Producer
Researchers at the University of Dundee have made new discoveries about the importance of nutrients for a subpopulation of T-cells...
Research opens new psoriasis treatment strategies
25 April 2016 | By Victoria White, Digital Content Producer
A VIB/UGent research team reveals the molecular signalling mechanism by which mutations in CARD14 lead to increased inflammation in patients with psoriasis...
